Jazz Pharmaceuticals (JAZZ) has had a rough couple of weeks. The drugmaker closed at $218.42 on Friday, Oct. 9, down about 11% over the...
pharmaceuticals
This is the web version of Eye on A.I., Fortune’s weekly newsletter on the news in artificial intelligence. To get...